Compass Therapeutics (CMPX) FCF Margin (2024)
Compass Therapeutics' FCF Margin history spans 1 years, with the latest figure at 1265.18% for Q2 2024.
- For Q2 2024, FCF Margin changed N/A year-over-year to 1265.18%; the TTM value through Mar 2025 reached 5204.35%, changed N/A, while the annual FY2024 figure was 5282.24%, N/A changed from the prior year.
- FCF Margin for Q2 2024 was 1265.18% at Compass Therapeutics.
- Across five years, FCF Margin topped out at 1265.18% in Q2 2024 and bottomed at 1265.18% in Q2 2024.